Patents by Inventor Lisbeth Hemmingsen

Lisbeth Hemmingsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel NIDDM Regimen
    Publication number: 20080027138
    Abstract: The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is stimulated in connection with meals by administering in connection with the meals a short-acting oral hypoglycaemic agent. Also, the present invention relates to a method of achieving significantly improvement in the glycaemic control by a combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone.
    Type: Application
    Filed: August 22, 2007
    Publication date: January 31, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Lisbeth Hemmingsen, Peter Muller
  • Novel NIDDM regimen
    Publication number: 20050222262
    Abstract: The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is stimulated in connection with meals by administering in connection with the meals a short-acting oral hypoglycaemic agent. Also, the present invention relates to a method of achieving significantly improvement in the glycaemic control by a combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone.
    Type: Application
    Filed: May 26, 2005
    Publication date: October 6, 2005
    Inventors: Lisbeth Hemmingsen, Peter Muller